Brand / Product	Market	Holder	Status	Expires
LEFNO-20 TABLET, COATED; ORAL	🇿🇼Zimbabwe	IPCA LABORATORIES LIMITED	active	Jan 2030
ARTHROD 20 mg	🇿🇦South Africa	Aurogen South Africa (Pty) Ltd	active	Aug 2029
EFIMIDEL 10 mg	🇿🇦South Africa	Aurogen South Africa (Pty) Ltd	active	Aug 2029
EFIMIDEL 20 mg	🇿🇦South Africa	Aurogen South Africa (Pty) Ltd	active	Aug 2029
ARTHROD 10 mg	🇿🇦South Africa	Aurogen South Africa (Pty) Ltd	active	Aug 2029
SOLIVO-20 TABLETS	🇷🇼Rwanda	EMCURE PHARMACEUTICALS LIMITED	active	Jul 2029
LEFUNAR 20	🇿🇦South Africa	Biotech Laboratories (Pty) Ltd	active	Mar 2029
LEFOSTEOMIDE 10	🇿🇦South Africa	Biotech Laboratories (Pty) Ltd	active	Mar 2029
LEFOSTEOMIDE 20	🇿🇦South Africa	Biotech Laboratories (Pty) Ltd	active	Mar 2029
LEFUNAR 10	🇿🇦South Africa	Biotech Laboratories (Pty) Ltd	active	Mar 2029
LEFLUNOMIDE 20 UNICORN	🇿🇦South Africa	Unicorn Pharmaceuticals (Pty) Ltd	active	Nov 2028
LEFRA-20 TABLET; ORAL	🇿🇼Zimbabwe	TORRENT PHARMACEUTICALS	active	Dec 2027
ARAVA 10 mg	🇿🇦South Africa	Sanofi-Aventis South Africa (Pty) Ltd	suspended	May 2025
ARAVA 20 mg	🇿🇦South Africa	Sanofi-Aventis South Africa (Pty) Ltd	suspended	Sept 2024
REDUPAR Comprimé pelliculé sécable / 100 mg	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Aug 2008
REDUPAR Comprimé pelliculé sécable / 10 mg	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Aug 2008
REDUPAR Comprimé pelliculé sécable / 20 mg	🇹🇳Tunisia	LES LABORATOIRES MEDIS	expired	Aug 2008
ARAVA Comprimé pelliculé / 20 MG	🇹🇳Tunisia	SANOFI-AVENTIS Deutschland GmbH	expired	Dec 2001
ARAVA Comprimé pelliculé / 10 MG	🇹🇳Tunisia	SANOFI-AVENTIS Deutschland GmbH	expired	Dec 2001
LUNAR 20	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Jan 1900
ADCO-LEFLUNOMIDE 20	🇿🇦South Africa	Adcock Ingram Limited	active	Jan 1900
ASPEN LEFLUNOMIDE 10 mg	🇿🇦South Africa	Pharmacare Limited û Woodmead	active	Jan 1900
LUNAR 100	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Jan 1900
RHEUNALEF 100	🇿🇦South Africa	Adcock Ingram Limited	active	Jan 1900
ADCO-LEFLUNOMIDE 100	🇿🇦South Africa	Adcock Ingram Limited	active	Jan 1900
LUNAR 10	🇿🇦South Africa	Cipla Medpro (Pty) Ltd	active	Jan 1900
ASPEN LEFLUNOMIDE 20 mg	🇿🇦South Africa	Pharmacare Limited û Woodmead	active	Jan 1900
ADCO-LEFLUNOMIDE 10	🇿🇦South Africa	Adcock Ingram Limited	active	Jan 1900
ARAVA COMPRIME PELLICULE	🇲🇦Morocco	—	active	—
lefora Solid Oral Film Coated Tablet	🇹🇿Tanzania	Kusum Healthcare Pvt. Ltd	active	—
ARAVA COMPRIME PELLICULE	🇲🇦Morocco	—	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	TORRENT PHARMACEUTICA LS LIMITED	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	TORRENT PHARMACEUTICA LS LIMITED	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	EVA PHARMA	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	TORRENT PHARMACEUTICA LS LIMITED	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	EVA PHARMA	active	—
Lefno-20 Tablets	🇹🇿Tanzania	IPCA Laboratories Limited	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	TORRENT PHARMACEUTICA LS LIMITED	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	EVA PHARMA	active	—
LEFLUNOMIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	EVA PHARMA	active	—
ARAVA COMPRIME PELLICULE	🇲🇦Morocco	—	active	—

LEFLUNOMIDE in Africa — Regulatory Overview

LEFLUNOMIDE is registered across 7 African markets with 41 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Tunisia, Morocco and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 41 registrations, 34 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.